AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
186.72
+1.39 (0.75%)
May 29, 2026, 11:02 AM EDT - Market open
AstraZeneca Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 12,914 | 12,402 | 8,691 | 6,899 | 2,501 | -265 |
Depreciation & Amortization | 5,815 | 5,733 | 6,688 | 5,387 | 5,480 | 6,530 |
Other Adjustments | 211 | 422 | 125 | 125 | -307 | -580 |
Change in Receivables | - | -1,728 | -1,624 | -1,425 | -1,349 | -961 |
Changes in Inventories | - | -755 | -131 | -669 | 3,941 | 1,577 |
Changes in Accounts Payable | - | 1,346 | 862 | 2,394 | 1,165 | 1,405 |
Changes in Income Taxes Payable | -3,008 | -2,845 | -2,750 | -2,366 | -1,623 | -1,743 |
Changes in Other Operating Activities | -510 | - | - | - | - | - |
Operating Cash Flow | 14,221 | 14,575 | 11,861 | 10,345 | 9,808 | 5,963 |
Operating Cash Flow Growth | 8.66% | 22.88% | 14.65% | 5.47% | 64.48% | 24.25% |
Capital Expenditures | -2,928 | -2,810 | -1,924 | -1,361 | -1,091 | -1,091 |
Sale of Property, Plant & Equipment | 20 | 13 | 55 | 132 | 282 | 13 |
Purchases of Intangible Assets | -3,546 | -3,095 | -2,662 | -2,417 | -1,480 | -1,109 |
Proceeds from Sale of Intangible Assets | 172 | 136 | 123 | 291 | 447 | 587 |
Purchases of Investments | -271 | -239 | -254 | -216 | -71 | -276 |
Proceeds from Sale of Investments | - | - | 91 | 32 | 42 | 785 |
Payments for Business Acquisitions | -1,125 | -1,230 | -3,779 | -1,015 | -820 | -9,906 |
Other Investing Activities | 331 | 417 | 370 | 490 | -269 | -61 |
Investing Cash Flow | -7,347 | -6,808 | -7,980 | -4,064 | -2,960 | -11,058 |
Short-Term Debt Issued | 1,599 | 364 | -31 | 161 | 74 | -552 |
Net Short-Term Debt Issued (Repaid) | 1,599 | 364 | -31 | 161 | 74 | -552 |
Long-Term Debt Issued | 2,005 | 15 | 6,492 | 3,816 | - | 25,858 |
Long-Term Debt Repaid | -2,027 | -2,029 | -4,652 | -4,942 | -1,271 | -9,518 |
Net Long-Term Debt Issued (Repaid) | -22 | -2,014 | 1,840 | -1,126 | -1,271 | 16,340 |
Issuance of Common Stock | 42 | 40 | 38 | 33 | 29 | 29 |
Repurchase of Common Stock | -647 | -521 | -81 | - | - | - |
Net Common Stock Issued (Repurchased) | -605 | -481 | -43 | 33 | 29 | 29 |
Common Dividends Paid | -4,911 | -4,971 | -4,629 | -4,481 | -4,364 | -3,856 |
Other Financing Activities | -630 | -442 | -1,133 | -1,154 | -1,418 | -687 |
Financing Cash Flow | -4,570 | -7,544 | -3,996 | -6,567 | -6,823 | 3,649 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 3 | 46 | -93 | -60 | -80 | -62 |
Net Cash Flow | 2,307 | 269 | -208 | -346 | -55 | -1,508 |
Free Cash Flow | 11,293 | 11,765 | 9,937 | 8,984 | 8,717 | 4,872 |
Free Cash Flow Growth | -4.01% | 18.40% | 10.61% | 3.06% | 78.92% | 26.94% |
FCF Margin | 18.68% | 20.03% | 18.38% | 19.61% | 19.65% | 13.02% |
Free Cash Flow Per Share | 3.62 | 3.77 | 3.18 | 2.88 | 2.79 | 1.71 |
Levered Free Cash Flow | 11,335 | 9,244 | 11,589 | 8,375 | 9,963 | 22,578 |
Unlevered Free Cash Flow | 10,890 | 12,009 | 10,849 | 10,464 | 12,819 | 6,220 |
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.